Key result
Intravascular lithotripsy supported by VA-ECMO (with or without IABP) was safely and effectively used to treat heavily calcified left main coronary lesions in two high-risk patients undergoing TAVR.
Why the study?
Pre-TAVR high-risk PCI for severely calcified left main lesions carries potential life-threatening complications, making the optimal choice of mechanical circulatory support device challenging.
Does intravascular lithotripsy combined with VA-ECMO (+/- IABP) safely facilitate high-risk PCI in patients with severely compromised LVF undergoing TAVR?
Case Report (n=2)
Does intravascular lithotripsy combined with VA-ECMO (+/- IABP) safely facilitate high-risk PCI in patients with severely compromised LVF undergoing TAVR?
Answers are grounded in this paper and cite their sources.
Intravascular lithotripsy combined with mechanical circulatory support (VA-ECMO +/- IABP) appears to be a safe and effective strategy for managing heavily calcified left main lesions in high-risk patients with severe LV dysfunction prior to TAVR.
BACKGROUND: Patients undergoing transcatheter aortic valve replacement (TAVR) usually have multiple comorbidities, such as severely impaired left ventricular function (LVF) and heavily calcified coronary lesions. When they undergo pre-TAVR high-risk percutaneous coronary interventions (HR-PCIs) for severely calcified left main (LM) lesions, potential life-threatening intra-procedural complications associated with the different techniques available to treat calcified lesions can arise. In this setting, mechanical circulatory support proves its usefulness. However, the choice of device can be troublesome. CASE SUMMARY: We report two clinical scenarios of intravascular lithotripsy (IVL) for the treatment of heavily calcified LM coronary lesions, wherein peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO), alone or combined with an intra-aortic balloon pump (IABP), were used as an upfront strategy to support the procedure. The use of these techniques was particularly effective during multi-vessel HR-PCIs and TAVR, and no complications occurred, which suggested their safety. DISCUSSION: These cases provide multiple insights into the strategy of using IVL + VA-ECMO, alone or with IABP, to treat heavily calcified LM coronary lesions in patients with severely compromised LVF undergoing TAVR. IVL safely and effectively overcame shortcomings related to other plaque ablation techniques, and VA-ECMO proved to be effective when facing the combination of high-risk coronary and valve interventions.
No takes yet. Share an insight, caveat, or question.
Marchese et al. (2021) conducted a case report in Heavily calcified left main coronary lesions in patients with severely compromised left ventricular function undergoing TAVR (n=2). Intravascular lithotripsy (IVL) with VA-ECMO, alone or with IABP was evaluated on Procedural safety and efficacy (no complications). Intravascular lithotripsy supported by VA-ECMO (with or without IABP) was safely and effectively used to treat heavily calcified left main coronary lesions in two high-risk patients undergoing TAVR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: